APLT Applied Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: APLT

Price (delayed)

$4.38

Market cap

$463.78M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.42

Enterprise value

$414.35M

Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company's lead drug candidate, ...

Highlights
APLT's debt is down by 48% year-on-year and by 13% since the previous quarter
The company's EPS rose by 35% YoY but it fell by 20% QoQ
The quick ratio has declined by 23% year-on-year but it has grown by 4.5% since the previous quarter
The equity has dropped by 55% since the previous quarter
The company's net income fell by 45% YoY and by 24% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.appliedtherapeutics.com
Peers: OCX OGEN OLMA OMER

Key stats

What are the main financial stats of APLT
Market
Shares outstanding
105.89M
Market cap
$463.78M
Enterprise value
$414.35M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
36.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
41.46
Earnings
Revenue
$9.99M
EBIT
-$119.76M
EBITDA
-$119.41M
Free cash flow
-$55.17M
Per share
EPS
-$1.42
Free cash flow per share
-$0.65
Book value per share
-$0.22
Revenue per share
$0.12
TBVPS
$0.65
Balance sheet
Total assets
$54.83M
Total liabilities
$71.98M
Debt
$467,000
Equity
-$17.15M
Working capital
-$16.8M
Liquidity
Debt to equity
-0.03
Current ratio
0.76
Quick ratio
0.7
Net debt/EBITDA
0.41
Margins
EBITDA margin
-1,194.9%
Gross margin
100%
Net margin
-1,198.5%
Operating margin
-645.8%
Efficiency
Return on assets
-275.8%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
-1,198.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

APLT stock price

How has the Applied Therapeutics stock price performed over time
Intraday
-7.59%
1 week
-15.12%
1 month
-30.03%
1 year
351.97%
YTD
30.75%
QTD
-35.59%

Financial performance

How have Applied Therapeutics's revenue and profit performed over time
Revenue
$9.99M
Gross profit
$9.99M
Operating income
-$64.54M
Net income
-$119.76M
Gross margin
100%
Net margin
-1,198.5%
The company's net income fell by 45% YoY and by 24% QoQ
APLT's net margin is down by 32% since the previous quarter
Applied Therapeutics's operating income has increased by 22% YoY but it has decreased by 3.3% from the previous quarter
The operating margin has decreased by 10% from the previous quarter

Growth

What is Applied Therapeutics's growth rate over time

Valuation

What is Applied Therapeutics stock price valuation
P/E
N/A
P/B
N/A
P/S
36.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
41.46
The company's EPS rose by 35% YoY but it fell by 20% QoQ
The equity has dropped by 55% since the previous quarter
APLT's P/S is 134% above its last 4 quarters average of 15.8
APLT's revenue is down by 6% since the previous quarter

Efficiency

How efficient is Applied Therapeutics business performance
The return on assets has dropped by 99% year-on-year and by 12% since the previous quarter
The company's return on sales fell by 32% QoQ

Dividends

What is APLT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for APLT.

Financial health

How did Applied Therapeutics financials performed over time
The company's total assets is 24% lower than its total liabilities
The total liabilities has soared by 110% YoY and by 28% from the previous quarter
The company's total assets rose by 43% YoY and by 21% QoQ
APLT's debt is 103% greater than its equity
The company's debt to equity has shrunk by 114% YoY but it rose by 40% QoQ
The equity has dropped by 55% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.